Delivery Order SPE2DR25D1109-SPE2DR26FFH6C
- Not listed
- The Defense Logistics Agency awarded a $27,437.03 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order is set to be completed by December 3, 2025, with performance at the vendor's...
- The Defense Logistics Agency awarded a $41,055.70 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and requires completion by December 5, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes valued at $3,603.02, with completion targeted for December 8, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $2,291.36 delivery order to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 mL syringes on October 14, 2025, with completion scheduled for October 15, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency has awarded a delivery order valued at $20,513.52 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes. The contract is non-competitive, firm fixed price, and scheduled for completion by September 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL syringes valued at $12,479.16. The contract, issued on December 2, 2025, with completion expected by December 3, 2025, utilizes firm fixed pricing with no set-aside designation. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion prime...
- The Defense Logistics Agency awarded a delivery order valued at $14,457.41 to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This is a firm fixed price, non-set-aside contract with a completion date of December 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $7,617.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes on November 10, 2025, with an ultimate completion date of November 12, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,709.46 for Dupixent 300 mg/2 mL syringes on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract...
- The Defense Logistics Agency awarded a $4,171.54 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFH6CDelivery Order
The Defense Logistics Agency awarded a $4,718.30 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL syringes on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. AmerisourceBergen Drug Corp serves as a critical vendor within the Defense Health Agency's medical supply chain, supplying pharmaceuticals and medical commodities to support military healthcare programs globally. The company's extensive federal contract portfolio demonstrates its capacity to meet federal procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order for Dupixent, a biologic medication used in dermatological and immunological treatments, reflects the company's ongoing role as a primary pharmaceutical supplier to the Department of Defense medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 12/7/25 |